Condrosulf's primary role is not pain relief but the significant retardation of the progression of arthritis. However, Condrosulf may assist in significantly reducing arthritic pain with the longer term use of Condrosulf. Condrosulf does not provide pain relief by masking the pain caused by the deterioration of joints but instead improves the health of the joint cartilage and has been demonstrated
in clinical trials to significantly improve the function of the joint. Patients taking Condrosulf in clinical trials have also been identified as being able to significantly reduce their consumption of pain relief medication. Condrosulf's active ingredients are a 98% pure medical grade chondroitins 4 and chondroitins 6 sulfate derived from shark. These isomers (types) of chondroitin sulfate are the only two isomers identified as being effective against arthritic pain. There are in fact many different forms of chondroitin sulfate. It is important to ensure that chondroitin used to assist with arthritic pain relief has been manufactured under appropriate quality controls and micro assay procedures to firstly, and most importantly, ensure the actual presence of 4 & 6 isomers, secondly, that they are present in sufficiently high concentrations and optimal ratios to be effective with a 800 mg daily dose. And finally, that the daily dose is a consistent, standardised daily dose that matches the clinical dose in medical trials. This is a fundamental distinction between medical grade product such as Condrosulf and health supplement/food grade chondroitins.
